Nebulizer Market to reach USD 2.05 billion by 2032, growing at a CAGR of 6.57% from 2024-2032.
The demand for nebulizers is primarily increasing due to the increasing incidence of chronic respiratory diseases like COPD. The estimated number of COPD cases worldwide will increase by 23% and reach nearly 600 million by 2050. Smoking and environmental pollution-related diseases are considered one of the major causes of developing respiratory conditions, and thus, a demand for efficient treatments like nebulizers was made. The average per-patient national COPD-attributable medical costs in 2020 were USD 1,895. They are projected to increase up to USD 3,083 by the year 2029, thus becoming another burden to healthcare systems.